Stay updated on RAS and Coagulopathy in COVID19 Clinical Trial
Sign up to get notified when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.

Latest updates to the RAS and Coagulopathy in COVID19 Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed older notices about government funding and prior Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice regarding government funding and NIH operations status has been added, and the site version has been updated from v3.4.0 to v3.4.1. This does not modify the study details, eligibility criteria, or results.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary is now displayed and QC metadata updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Older QC entries and 'No FEAR Act' data have been removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page, as shown in the screenshots. This appears to be a metadata/version update and does not alter the study details or results.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now lists Revision: v3.3.3 added. HHS Vulnerability Disclosure and Revision: v3.3.2 removed.SummaryDifference0.1%

- Check92 days agoChange DetectedPublication description updated from 'are about the study results' to 'are about the results of the study', and a page footer shows 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to RAS and Coagulopathy in COVID19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.